cilomilast has been researched along with Prostatic Neoplasms in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Beebe, DJ; Bushman, W; Domenech, M; Frantskevich, K; Hammer, KD; Malinowski, RL; Marker, PC; Powers, GL | 1 |
1 other study(ies) available for cilomilast and Prostatic Neoplasms
Article | Year |
---|---|
Phosphodiesterase 4D inhibitors limit prostate cancer growth potential.
Topics: Animals; Cell Proliferation; Cyclic Nucleotide Phosphodiesterases, Type 4; Cyclohexanecarboxylic Acids; Hedgehog Proteins; Humans; Male; Mice; Mitogen-Activated Protein Kinase Kinases; Naphthyridines; Nitriles; Oxadiazoles; Phosphodiesterase 4 Inhibitors; Prostatic Neoplasms; Receptors, Androgen; Signal Transduction; Xenograft Model Antitumor Assays | 2015 |